华熙生物：股东国寿成达减持57.18万股公司股份

Core Viewpoint - Huaxi Biological (688363.SH) announced a share reduction plan implemented by its shareholder Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership), indicating a decrease in shareholding percentage [1] Group 1 - On November 26, 2025, Guoshou Chengda reduced its holdings by 571,800 shares through centralized bidding [1] - Following the reduction, Guoshou Chengda's shareholding decreased from 28,936,500 shares to 28,364,700 shares [1] - The percentage of total shares held by Guoshou Chengda fell from 6.01% to 5.89%, reaching a 1% integer threshold [1]